Increasing preference for safe and accurate drug delivery systems, technological advancements in drug infusion systems, and seamless integration of drug infusion systems with electronic health records are some key factors expected to drive market growth.
Emergen Research: Drug Infusion Systems Market By Control Systems (Open Loop System, Closed Loop System), By Infusion Type (Continuous Infusion, Intermittent Infusion, Patient Controlled Infusion, Total Parenteral Nutrition), By Administration Route, By Application, By End-Use, and By Region Forecast to 2028
Increasing preference for safe and accurate drug delivery systems, technological advancements in drug infusion systems, and seamless integration of drug infusion systems with electronic health records are some key factors expected to drive market growth
According to Emergen Research, the global drug infusion systems market size was USD 10.56 Billion in 2020 and is expected to reach USD 18.17 billion in 2028 and register a revenue CAGR of 7.1%, during the forecast period, 2021-2028.
Market Dynamics:
Drug infusion systems are used to deliver fluids or therapeutics into the body of a patient’s body in controlled manner. There are a wide range of infusion pumps available in the market that are used for various applications in different clinical settings. Over the recent, technological advancements in drug infusion systems have enabled them to be electrically networked together for bidirectional circulation of information such as updated drug libraries.
Click Here to Access Free sample PDF Copy of the Report@ https://www.emergenresearch.com/request-sample/692
Drug infusion systems offer numerous advantages over other administration modes such as ability to deliver fluids in very small volumes in a controlled manner and ability to deliver fluids at programmed rates and automated intervals. Increasing use of drug infusion systems to reduce rates of adverse drug events, availability of cost-effective smart drug infusion pumps, and growing focus on reducing medical errors are some key factors expected to drive market revenue growth over the forecast period.
Smart infusion systems have been designed to minimize programming errors and related risk to patients and these systems are equipped with customized infusion system drug library that includes dosing ranges and other safety limits for individual drugs. This library ensures effective and safe use of drug infusion systems and these rapid technological advancements is another factor expected to drive market growth going ahead. Commercial target-controlled infusion systems are available in the market that minimize the risk of embolization, limit the amount of therapeutics that are released in systemic circulation, reduces risk of bleeding complications, and minimizes risk of fluid imbalance. Increasing preference for self-controlled drug infusion systems, advancements in closed-loop infusion systems, and growing prevalence of chronic diseases such as diabetes are factors expected to create demand for drug infusion systems and contribute to market growth going ahead. However, software defects, user interface issues, and mechanical or electrical failures can cause malfunctioning of infusion systems and can hamper market growth to a certain extent going ahead.
COVID-19 Impact Analysis
- Social distancing and restrictions severely disrupted businesses and operations
- Lockdowns caused disruptions in transportation and logistics
- Impacted manufacturing activities and mining operations globally
- Took a toll on economy of various countries
- Caused sudden and drastic downturn in economic activity
- Disrupted agriculture, fisheries, dairy, and other sectors
- Caused loss of employment and financial crisis
- Supply impacts were further compounded owing to reduced disposable income
- Emergence of variants continue to cause concerns and impact normal routines
Closed-loop System Segment Revenue to Support Market Growth:
Closed-loop system segment is expected to account for significantly large revenue share over the forecast period attributable to increasing use of closed-loop systems to automate drug infusion, ability of closed loop systems to improve intravenous drug administration, and capability of closed-loop systems to enhance safety and efficacy of therapeutics. In addition, advancements in bioresponsive closed-loop drug delivery systems, growing focus on improving hemostatic regulation, and increasing use of closed-loop systems in treatment of certain diseases such as thrombosis and bacterial infection are some other factors expected to drive revenue growth of the segment over the forecast period.
Looking for Discount [Click on the link] @ https://www.emergenresearch.com/request-discount/692
Intravenous Segment to Register Significant Revenue Growth:
Intravenous segment is expected to register rapid revenue CAGR over the forecast period attributable to increasing preference for intravenous route for delivery of medicines and therapeutics such as insulin and antibiotics, increasing bioavailability of drugs through intravenous route, and convenient and safe mode of administration. Intravenous administration avoids the first-pass drug effect which results in direct entry of the drug into the systemic circulation and leads to immediate drug effect. It also enables control of the administration rate and reduces chances of adverse effects and these are some other factors expected to contribute to revenue growth of the segment during the forecast period.
North America to Dominate Other Regions in Terms of Revenue Share:
North America is expected to account for largest revenue share over the forecast period over the forecast period attributable to increasing prevalence of chronic diseases, availability of cost-effective medical devices, favorable reimbursement scenarios, advanced healthcare facilities, increasing demand for high-quality healthcare facilities due to rising disposable income among individuals, and presence of key market players in the region.
Major Companies in the Market Include:
- Medtronic Plc
- Arcomed Ag
- Baxter International Inc.
- Insulet Corporation
- Smiths Group Plc
- Becton, Dickinson and Company
- Halyard Health, Inc.
- ICU Medical, Inc.
- Flowonix Medical Inc.
- Zyno Medical LLC
Have a look at Report Description and Table of Contents of Market Report@ https://www.emergenresearch.com/industry-report/drug-infusion-systems-market
For the purpose of this report, Emergen Research has segmented the global drug infusion systems market on the basis of control systems, infusion type, administration route, application, end-use, and region:
Control Systems Outlook (Revenue, USD Billion; 2018–2028)
- Open Loop System
- Closed Loop System
Infusion Type Outlook (Revenue, USD Billion; 2018–2028)
- Continuous Infusion
- Intermittent Infusion
- Patient Controlled Infusion
- Total Parenteral Nutrition
Administration Route Outlook (Revenue, USD Billion; 2018–2028)
- Enteral
- Subcutaneous
- Intravenous
- Arterial
- Epidural
Application Outlook (Revenue, USD Billion; 2018–2028)
- Pediatrics
- Diabetes
- Nutrition
- Hematology
- Analgesia
- Chemotherapy
- Others
End-Use Outlook (Revenue, USD Billion; 2018–2028)
- Diagnostic Centers
- Hospitals
- Ambulatory Surgical Centers
- Others
Regional Outlook (Revenue, USD Billion; 2018–2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Turkey
- Rest of MEA
Latest Published Reports by Emergen Research:
High Precision Asphere Market Size, Share, Trends, By Product Type (Glass Aspherical Lens, Plastic Aspherical Lens), By Application (Automotive, Cameras, Mobile Phones and Tabs, Optical Instrument, Others), and By Region Forecast to 2028.
Camouflage Coatings Market By Product Type (Liquid Coating, Spray Coating, Others), By Application (Defense, Textile, Aircrafts, Others), and By Region Forecast to 2028.
Bio isobutene market By Product Type (Methyl Tert-butyl Ether, Ethyl Tert-butyl Ether), By Application (Automotive, Aerospace, Antioxidants, Pharmaceuticals), and By Region Forecast to 2028.
Lead free Piezoelectric Ceramic Material Market By Product Type (Barium Titanate Base, Bismuth Titanate Sodium Group, Niobium Acid-Base, Others), By Application (Industry & Manufacturing, Automotive Industry, Consumer Electronics, Medical, Others), and By Region Forecast to 2030.
Cool Roof Coating Market By Technology (Water Based, Solvent Based), By Application (Low-sloped, Steep-sloped, Others), By Product (IR Reflective/Colored, Elastomeric/White), By End-use, and By Region Forecast to 2028.
Green Methanol Market Size, Share, Trends, By Feedstock (Agricultural Waste, Forestry Residues, Municipal Solid Waste, CO2 Emission, Others), By Application (Formaldehyde, Methyl-Tert-Butyl-Ether, Others), By End-Use, and By Region Forecast to 2030.
Bisphenol A Market, By Application (Epoxy Resins, Polycarbonate Resins, Unsaturated Polyester Resins, Flame Retardants, Polysulfone Resins, Polyacrylate), By Industry Vertical (Automotive, Electronics, Medical, Paints & Coatings, Packaging), By Distribution Channel (Direct, Indirect), and By Region Forecast to 2028
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Read Our Press release@ https://www.emergenresearch.com/press-release/global-drug-infusion-systems-market